Treatment of Localized MRSA Infection Around a PEG Tube
For a localized MRSA infection around a PEG tube, treat with oral clindamycin 600 mg three times daily, oral TMP-SMX (trimethoprim-sulfamethoxazole), or doxycycline for 5-10 days, combined with local wound care including incision and drainage if an abscess is present 1.
Classification and Treatment Approach
The infection around a PEG tube should be classified as a skin and soft tissue infection (SSTI). The treatment algorithm depends on whether the infection is purulent or nonpurulent:
For Purulent Infections (with drainage, exudate, or abscess):
- Primary intervention: Incision and drainage if an abscess is present 1
- Antibiotic therapy is indicated when there is:
- Extensive disease or multiple sites
- Rapid progression with associated cellulitis
- Signs of systemic illness
- Failure to respond to drainage alone 1
Outpatient Oral Antibiotic Options (in order of preference):
- Clindamycin 600 mg PO three times daily (covers both MRSA and streptococci) 1
- TMP-SMX (double-strength) twice daily - requires addition of amoxicillin if streptococcal coverage needed 1
- Doxycycline or minocycline - also requires addition of a beta-lactam for streptococcal coverage 1
- Linezolid 600 mg PO twice daily (covers both MRSA and streptococci, but more expensive) 1
For Hospitalized Patients with Complicated Infection:
If the patient requires hospitalization due to severity, systemic toxicity, or failed outpatient management:
- IV vancomycin 15-20 mg/kg/dose every 8-12 hours 1
- Linezolid 600 mg IV/PO twice daily 1
- Daptomycin 4 mg/kg IV once daily 1
- Clindamycin 600 mg IV three times daily (if local resistance <10%) 1
Duration of Therapy
Treat for 5-10 days based on clinical response 1. The infection should show improvement within 48-72 hours. If no improvement occurs, reassess for:
- Undrained abscess requiring surgical intervention
- Alternative or polymicrobial infection
- Antibiotic resistance (obtain cultures if not already done)
Critical Wound Care Measures
Beyond antibiotics, proper wound management is essential:
- Keep the site covered with clean, dry bandages 1
- Clean hands with soap and water or alcohol-based gel after touching the site 1
- Avoid sharing personal items that contact the wound 1
- Clean high-touch surfaces regularly 1
Important Caveats
Do NOT use rifampin as monotherapy or adjunctive therapy for SSTI 1. While the research evidence shows that MRSA colonization significantly increases PEG site infection risk (57% in colonized patients vs 15% in non-colonized) 2, and that decontamination protocols can reduce infection rates 3, 4, these studies address prevention rather than treatment of established infection.
Clindamycin is the preferred single agent because it provides coverage for both MRSA and beta-hemolytic streptococci, which can co-infect these sites 1. However, this assumes local clindamycin resistance rates are acceptable (<10%). If resistance rates are higher in your institution, TMP-SMX plus a beta-lactam or linezolid alone are appropriate alternatives.
The pediatric dosing differs: clindamycin 10-13 mg/kg/dose every 6-8 hours (maximum 40 mg/kg/day), and tetracyclines should be avoided in children under 8 years of age 1.